Latest Breaking News On - பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம் - Page 13 : vimarsana.com

New Oklahoma Pediatric Psychotropic Medication Resource Guide released for health care professionals

By Darla Shelden, City Sentinel Reporter –

United statesUniversity of oklahomaOklahoma state universityDeborah shropshireDarla sheldenSara coffeyAmerican academy of pediatricsOklahoma health care authorityUniversity of oklahoma health sciences centerUniversity of oklahoma centerTelligen community initiativeChild welfare servicesOklahoma state university centerOklahoma department of human servicesBehavioral sciencesHealth sciences

Achievers: OU cancer center researcher named to national organization

The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Rajagopal Ramesh, OU Health Stephenson Cancer Center researcher and professor in the Department of Pathology at the University of Oklahoma Health Sciences Center, to its College of Fellows. Ramesh was nominated, reviewed and elected by peers and members of the College of Fellows for outstanding contribution in clinical translation of cancer gene therapeutics using biological and synthetic materials. The College of Fellows is composed of the top 2% of medical and biological engineers in the country. A formal induction ceremony will be held during AIMBE’s 2021 annual event on March 26.

United statesRajagopal rameshUniversity of oklahoma health sciences centerCollege of fellowsDepartment of pathologyAmerican institute forOu health stephenson cancer centerAmerican instituteBiological engineeringStephenson cancer centerOklahoma health sciences centerOklahoma cityHigher educationஒன்றுபட்டது மாநிலங்களில்ராஜகோபால் ரமேஷ்பல்கலைக்கழகம் ஆஃப் ஓக்லஹோமா ஆரோக்கியம் அறிவியல் மையம்

Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers

AUSTIN, Texas, Feb 23, 2021 (SEND2PRESS NEWSWIRE) Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings. The HEPtune platform, which utilizes heparosan, a naturally occurring polysaccharide, has been validated as a novel half-life extension and drug delivery alternative to commonly used polyethylene glycol (PEG). Unlike PEG, heparosan is naturally found in humans, is completely biodegradable, and will not trigger anaphylactic shock or anti-drug antibodies. The HEPtune platform has been applied to numerous drug classes including biologics, and small molecules via nanocarriers, including liposomes.

United statesPaul deangelisEmergent technologies incCaisson biotechEuropean patent officeUniversity of oklahoma health sciences centerStanford universityUniversity of oklahoma professor drPresidential professorOklahoma health sciences centerChief scientistOklahoma professorEmergent technologiesஒன்றுபட்டது மாநிலங்களில்வெளிப்படுகிறது தொழில்நுட்பங்கள் இன்க்கெயிசன் பயோடெக்

Caisson Biotech and Heparinex Announce Positive Exam Report of European Patent and the Discovery of a New Class of Sugar Polymers

Caisson Biotech and Heparinex Announce Positive Exam Report of European Patent and the Discovery of a New Class of Sugar Polymers
enewschannels.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from enewschannels.com Daily Mail and Mail on Sunday newspapers.

United statesPaul deangelisEmergent technologies incCaisson biotechEuropean patent officeUniversity of oklahoma health sciences centerStanford universityUniversity of oklahoma professor drPresidential professorOklahoma health sciences centerChief scientistOklahoma professorEmergent technologiesஒன்றுபட்டது மாநிலங்களில்வெளிப்படுகிறது தொழில்நுட்பங்கள் இன்க்கெயிசன் பயோடெக்

Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers

Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers
floridanewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from floridanewswire.com Daily Mail and Mail on Sunday newspapers.